Francesca Vanni

689 total citations
16 papers, 419 citations indexed

About

Francesca Vanni is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Francesca Vanni has authored 16 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Immunology. Recurrent topics in Francesca Vanni's work include Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Influenza Virus Research Studies (2 papers). Francesca Vanni is often cited by papers focused on Cardiac electrophysiology and arrhythmias (4 papers), Cardiac Arrhythmias and Treatments (3 papers) and Influenza Virus Research Studies (2 papers). Francesca Vanni collaborates with scholars based in Italy, United States and Belgium. Francesca Vanni's co-authors include Franco Laghi‐Pasini, Pier Leopoldo Capecchi, Pietro Enea Lazzerini, Francesco Finizola, Iacopo Bertolozzi, Mohamed Boutjdir, Enrico Selvi, Mariarita Natale, Gabriele Cevenini and Maurizio Acampa and has published in prestigious journals such as The Lancet, Heart and European Journal of Medicinal Chemistry.

In The Last Decade

Francesca Vanni

14 papers receiving 415 citations

Peers

Countries citing papers authored by Francesca Vanni

Since Specialization

Citations

This map shows the geographic impact of Francesca Vanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Vanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Vanni more than expected).

Fields of papers citing papers by Francesca Vanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Vanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Vanni. The network helps show where Francesca Vanni may publish in the future.

Co-authorship network of co-authors of Francesca Vanni

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Vanni. A scholar is included among the top collaborators of Francesca Vanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Vanni. Francesca Vanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults 2025 ·Vaccines ·Valentino D’Onofrio, (unknown), (unknown), (unknown), Matthias Verstraete, (unknown), (unknown), Fien De Boever, (unknown), Geert Leroux–Roels, (unknown), Francesca Vanni, Alessandro Manenti, Peter Paul Platenburg, Luuk Hilgers, Isabel Leroux‐Roels	0
2	Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine targeting serogroups A, C, W, Y, and X when co-administered with routine childhood vaccines at ages 9 months and 15 months in Mali: a single-centre, double-blind, randomised, controlled, phase 3, non-inferiority trial 2025 ·The Lancet ·Fatoumata Diallo, Fadima Cheick Haidara, Milagritos D. Tapia, Clara P. Domínguez Islas, Mark R. Alderson, William P. Hausdorff, Lionel Martellet, Nancy Hosken, (unknown), Prasad S. Kulkarni, (unknown), Francesca Vanni, Christine M. Posavad, Samba O. Sow, Karen L. Kotloff, Wilbur H. Chen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
3	Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study 2024 ·Vaccines ·Valentino D’Onofrio, (unknown), (unknown), (unknown), Fien De Boever, (unknown), (unknown), Francesca Vanni, Alessandro Manenti, Geert Leroux–Roels, Peter Paul Platenburg, Luuk Hilgers, Isabel Leroux‐Roels	1
4	Validation of a double-color ELISpot assay of IFN-γ and IL-4 production in human peripheral blood mononuclear cells 2023 ·Journal of Immunological Methods ·(unknown), (unknown), Camilla Marrocco, Pietro Piu, (unknown), (unknown), (unknown), Giulia Piccini, Martina Monti, Francesca Vanni, (unknown), Ilaria Manini, Emanuele Montomoli, Alessandro Manenti	2
5	The starving heart 2022 ·European Heart Journal - Cardiovascular Imaging ·Valentina Scheggi, Francesca Vanni, (unknown), Andrea Rinaldi, (unknown), (unknown), Giovanni Castellini, B Alterini, Niccolò Marchionni, Valdo Ricca	1
6	A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis 2021 ·Pharmacological Research ·Francesca Vanni, (unknown), (unknown), Anna Kabanova, Francesca Cattaneo, Anna Sicuranza, Alessandro Gozzetti, Sandra Gemma, Daniela M. Zisterer, Monica Bocchia, Giuseppe Campiani, Cosima T. Baldari, Stefania Butini, Cristina Ulivieri	1
7	Cardiac Arrest Risk During Acute Infections 2020 ·Circulation Arrhythmia and Electrophysiology ·Pietro Enea Lazzerini, Maurizio Acampa, Franco Laghi‐Pasini, Iacopo Bertolozzi, Francesco Finizola, Francesca Vanni, Mariarita Natale, Stefania Bisogno, Gabriele Cevenini, Alessandra Cartocci, (unknown), (unknown), (unknown), (unknown), Massimo Maccherini, Mohamed Boutjdir, Pier Leopoldo Capecchi	41
8	Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation 2020 ·European Journal of Medicinal Chemistry ·Nicola Relitti, A. Prasanth Saraswati, Giulia Chemi, Margherita Brindisi, Simone Brogi, Daniel Herp, (unknown), Fulvio Saccoccia, Giovina Ruberti, Cristina Ulivieri, Francesca Vanni, Federica Sarno, Lucia Altucci, Stefania Lamponi, Manfred Jung, Sandra Gemma, Stefania Butini, Giuseppe Campiani	30
9	Development and characterization of a suturable biomimetic patch for cardiac applications 2019 ·Journal of Materials Science Materials in Medicine ·Elisabetta Rosellini, Luigi Lazzeri, S. Maltinti, Francesca Vanni, Niccoletta Barbani, Maria Grazia Cascone	10
10	3-Amino-alkylated Indoles: Unexplored Green Products Acting As anti-inflammatory Agents 2019 ·Future Medicinal Chemistry ·Sarah Mazzotta, Luca Frattaruolo, Matteo Brindisi, Cristina Ulivieri, Francesca Vanni, Antonella Brizzi, Gabriele Carullo, Anna Rita Cappello, Francesca Aiello	23
11	Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin‐6–Mediated Changes in Connexin Expression 2019 ·Journal of the American Heart Association ·Pietro Enea Lazzerini, Franco Laghi‐Pasini, Maurizio Acampa, Ujala Srivastava, Iacopo Bertolozzi, (unknown), Francesco Finizola, Francesca Vanni, Aleksander Dokollari, Mariarita Natale, Gabriele Cevenini, Enrico Selvi, (unknown), Massimo Maccherini, Mohamed Boutjdir, Pier Leopoldo Capecchi	123
12	Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes 2018 ·Frontiers in Pharmacology ·Pietro Enea Lazzerini, Iacopo Bertolozzi, Francesco Finizola, Maurizio Acampa, Mariarita Natale, Francesca Vanni, Rosella Fulceri, Alessandra Gamberucci, Marco Rossi, (unknown), M. Caselli, (unknown), Gabriele Cevenini, Franco Laghi‐Pasini, Pier Leopoldo Capecchi	27
13	Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts 2017 ·Frontiers in Pharmacology ·Daniela Gentile, Pietro Enea Lazzerini, Alessandra Gamberucci, Mariarita Natale, Enrico Selvi, Francesca Vanni, (unknown), Paolo Taddeucci, (unknown), Manuela Cabiati, (unknown), David Abraham, Maria Aurora Morales, Rosella Fulceri, Franco Laghi‐Pasini, Pier Leopoldo Capecchi	15
14	Systemic inflammation as a novel QT-prolonging risk factor in patients with torsades de pointes 2017 ·Heart ·Pietro Enea Lazzerini, Franco Laghi‐Pasini, Iacopo Bertolozzi, (unknown), Sauro Lorenzini, Antonella Simpatico, Enrico Selvi, Maria Romana Bacarelli, Francesco Finizola, Francesca Vanni, Deana Lazaro, Ademuyiwa S. Aromolaran, (unknown), Mohamed Boutjdir, Pier Leopoldo Capecchi	79
15	Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 2016 ·Cell Death Discovery ·(unknown), Gabriella Misso, Pierpaolo Pastina, Susan Costantini, Francesca Vanni, Claudia Gandolfo, Cirino Botta, Francesca Capone, Angela Lombardi, Luigi Pirtoli, Pierfrancesco Tassone, Cristina Ulivieri, Pierosandro Tagliaferri, Maria Grazia Cusi, Michele Caraglia, Pierpaolo Correale	64
16	Two new butyrophenone derivatives studied with the conditioned reflex technique. 1961 ·PubMed ·(unknown), Francesca Vanni	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact